about
Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein ThrombosisComparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-AnalysisPredicting the risk of venous thromboembolism recurrenceNew oral anticoagulants for the treatment of venous thromboembolism: understanding differences and similaritiesThe epidemiology of venous thromboembolismSex-specific effect of CPB2 Ala147Thr but not Thr325Ile variants on the risk of venous thrombosis: A comprehensive meta-analysisResidual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study.Association between TLR9 rs5743836 polymorphism and risk of recurrent venous thromboembolism.Correlates of in-hospital deaths among hospitalizations with pulmonary embolism: findings from the 2001-2008 National Hospital Discharge Survey2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.Optimal duration of anticoagulation after venous thromboembolism.Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism.Male mice have increased thrombotic potential: sex differences in a mouse model of venous thrombosisRecurrent hospitalization and healthcare resource use among patients with deep vein thrombosis and pulmonary embolism: findings from a multi-payer analysis.Venous thromboembolism in patients with reduced estimated GFR: a population-based perspectiveOutpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer.Myeloid cell tissue factor does not contribute to venous thrombogenesis in an electrolytic injury model.Systematic review of the complications following isolated calf deep vein thrombosis.Taller women are at greater risk of recurrent venous thromboembolism: the Iowa Women's Health Study.New insights into the mechanisms of venous thrombosis.Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?Epidemiology of recurrent venous thrombosisFactors determining altered perfusion after acute pulmonary embolism assessed by quantified single-photon emission computed tomography-perfusion scan.Update on perioperative bridging in patients on chronic oral anticoagulation.Impact of venous thromboembolism on clinical management and therapy after hip and knee arthroplasty.Pulmonary embolism: risk assessment and management.A practical approach to the use of low molecular weight heparins in VTE treatment and prophylaxis in children and newborns.How D-dimer assay can be useful in deciding the duration of anticoagulation after venous thromboembolism: a review.Dabigatran for the treatment of venous thromboembolism.Direct Oral Anticoagulants for the Management of Thromboembolic Disorders: The Importance of Adherence and Persistence in Achieving Beneficial Outcomes.Edoxaban: A Review in Deep Vein Thrombosis and Pulmonary Embolism.Determinants of treatment duration in the prevention of recurrent venous thromboembolism: a protocol for a balanced vignette experiment.The safety of fondaparinux sodium for the treatment of venous thromboembolism.Statins and venous thromboembolism: do they represent a viable therapeutic agent?Venous thromboembolism: risk factors, biomarkers, and treatment.Cardiac arrest caused by multiple recurrent pulmonary embolism.Risk factors for pulmonary embolism in patients preliminarily diagnosed with community-acquired pneumonia: a prospective cohort study.Effectiveness of digital infrared thermal imaging in detecting lower extremity deep venous thrombosis.Role of family history of venous thromboembolism and thrombophilia as predictors of recurrence: a prospective follow-up study.
P2860
Q26749273-77ED46F7-C702-4A69-8779-DBF32DBF44D9Q26771581-57A38894-742D-4A0C-BBBA-34E16DA50029Q26865059-E2B23348-BF4B-4BD1-8024-F383390375C8Q27001528-70A99A5F-5FFB-4D92-B385-C6E11E018CA5Q28067893-03855DD3-D06E-4507-854E-3810956D6C6FQ33731941-10A17E07-CE7E-4028-B776-9B0BACDF6B59Q33821311-B1DAB399-A4E4-48CC-ABBC-7913D5B89103Q33841714-A179B877-9385-42AC-8C5E-ED4F63EDA281Q34335591-CAA8F9EE-4B62-4D2C-B783-C805D5D87A8DQ34436061-0FE206AF-1918-4D7E-B3A3-EFEDCC3BADCCQ34781477-63B1B8B0-5CF0-4B3C-B502-A9D37F4E2A1EQ34788985-470AE183-EEF0-4810-9CA7-410F28C0C203Q34851729-4EEE450D-1275-4461-906C-05D582B70F0CQ35232454-CA331FA9-F37E-4329-9875-1FC9019B06A8Q35479128-CE00EF49-9D70-4EF1-8996-316D9D2B7BEFQ35863905-82005194-F6DC-4F89-8B0F-89555D1E3F91Q35911572-E4B4D50A-A99C-4E2A-A3F8-C4A788EEC189Q35984288-669CBC98-3309-47F3-B6B5-350CF51A357CQ36032737-BD10AE05-9EB7-4018-BAD3-E77EADB84B84Q36068279-E27EC7EB-60A7-43C8-B79B-EBC417CC1D3AQ36093916-56B95FBA-6339-42B6-86FC-208439960F8BQ36201247-30FC0869-C8FA-4171-AA66-14C55FA27CFBQ37370722-838C59C6-8F47-4DD3-925B-4F172835B9BAQ37604420-988C3BC8-085E-4E0D-AC5B-5D8E08ED5686Q37642825-06196901-8252-4800-873E-72AB8C12AE77Q37903077-6BF6B400-E0F2-4809-ABE4-9450F4E5DEC5Q38042025-9F4FA167-3B1A-4EF5-9875-3F04AADD0FEEQ38261097-7845CA43-C2DC-44BA-A701-ED8ED09260EAQ38263114-CB61C4A0-9826-463B-90D0-7CB06284C4F1Q38537977-AB048819-FAD0-42DF-8B41-01E44C143C49Q38575711-ABB7DADC-C323-456E-9AE7-3B098DA09074Q38627495-ADFA5AC4-1592-4F58-89D3-C2056BF0BFD0Q38791010-5F6C9FCE-3F82-4C18-9708-943861CA0139Q38930816-2D8DCB41-B9FA-4615-9665-C832861A0E6FQ39445730-23A3BED1-D374-42B7-966E-491D9197C969Q39476602-3417F96F-4F03-4FEE-85C8-2325416B00B9Q39488389-976D9CDC-B4A0-4120-A2B1-50BC0F4DAEF7Q40139422-FED1200A-932F-48FF-AC02-E0F99D80939FQ40280873-C0EC1C79-26E9-41FA-963E-25B81D68F34DQ40499885-AF214257-F8D9-492C-B6B9-D17BDE52384C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Venous thromboembolism: risk factors for recurrence.
@en
Venous thromboembolism: risk factors for recurrence.
@nl
type
label
Venous thromboembolism: risk factors for recurrence.
@en
Venous thromboembolism: risk factors for recurrence.
@nl
prefLabel
Venous thromboembolism: risk factors for recurrence.
@en
Venous thromboembolism: risk factors for recurrence.
@nl
P2093
P1476
Venous thromboembolism: risk factors for recurrence.
@en
P2093
Isabelle Martinez
Joseph Emmerich
Tienan Zhu
P304
P356
10.1161/ATVBAHA.108.182428
P407
P577
2009-03-01T00:00:00Z